tiprankstipranks
Trending News
More News >
Geron Corp (GERN)
NASDAQ:GERN
US Market

Geron (GERN) Stock Forecast & Price Target

Compare
2,549 Followers
See the Price Targets and Ratings of:

GERN Analyst Ratings

Strong Buy
5Ratings
Strong Buy
4 Buy
1 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Geron
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GERN Stock 12 Month Forecast

Average Price Target

$4.00
▲(200.75% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Geron in the last 3 months. The average price target is $4.00 with a high forecast of $5.00 and a low forecast of $3.00. The average price target represents a 200.75% change from the last price of $1.33.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","3":"$3","6":"$6","1.5":"$1.5","4.5":"$4.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.5,3,4.5,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.32,1.603076923076923,1.8861538461538463,2.1692307692307695,2.4523076923076923,2.735384615384615,3.0184615384615388,3.3015384615384615,3.5846153846153843,3.867692307692308,4.150769230769231,4.4338461538461535,4.716923076923077,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.32,1.5261538461538462,1.7323076923076923,1.9384615384615385,2.144615384615385,2.350769230769231,2.556923076923077,2.763076923076923,2.9692307692307693,3.1753846153846155,3.3815384615384616,3.5876923076923077,3.793846153846154,{"y":4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.32,1.4492307692307693,1.5784615384615386,1.7076923076923078,1.8369230769230769,1.9661538461538464,2.0953846153846154,2.224615384615385,2.353846153846154,2.483076923076923,2.6123076923076924,2.741538461538462,2.8707692307692305,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.54,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.87,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.17,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.26,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 62, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.19,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 61, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 56, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5.00Average Price Target$4.00Lowest Price Target$3.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$4$3
Buy
125.56%
Upside
Reiterated
01/29/26
TD Cowen Sticks to Their Buy Rating for Geron (GERN)
Wedbush Analyst forecast on GERN
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$5
Buy
275.94%
Upside
Reiterated
01/13/26
Wedbush Remains a Buy on Geron (GERN)
H.C. Wainwright Analyst forecast on GERN
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
01/12/26
Geron: Tempered 2026 Outlook with Execution Risks and Operational Offsets Supports Hold Rating
Needham Analyst forecast on GERN
Needham
Needham
$4
Buy
200.75%
Upside
Reiterated
01/12/26
Balancing Softer Near-Term Guidance with Capital Discipline and Pipeline Catalysts: Why Geron Merits a Buy Rating and $4 Target
Barclays Analyst forecast on GERN
Barclays
Barclays
$4
Buy
Reiterated
11/03/25
Barclays Sticks to Its Buy Rating for Geron (GERN)
Leerink Partners Analyst forecast on GERN
Leerink Partners
Leerink Partners
$3
Buy
125.56%
Upside
Reiterated
08/12/25
Geron Inc.: Buy Rating Affirmed Amid Promising Leadership and Growth Prospects
Scotiabank Analyst forecast on GERN
Scotiabank
Scotiabank
$1.5
Hold
12.78%
Upside
Reiterated
08/07/25
Scotiabank Reaffirms Their Hold Rating on Geron (GERN)
Goldman Sachs Analyst forecast on GERN
Goldman Sachs
Goldman Sachs
$1
Sell
-24.81%
Downside
Reiterated
07/18/25
We resumed coverage of the Emerging Biotechnology sector last week, including 19 stocks, with Buy ratings on AMLX, AVBP, RNA, CGON, NBIX, RYTM, ROIV, and SNDX, and Sell ratings on ALT and GERN.
Stifel Nicolaus Analyst forecast on GERN
Stifel Nicolaus
Stifel Nicolaus
$4
Buy
200.75%
Upside
Reiterated
03/12/25
Stifel Nicolaus Sticks to Its Buy Rating for Geron (GERN)
Wolfe Research Analyst forecast on GERN
Wolfe Research
Wolfe Research
$3.5$2
Hold
50.38%
Upside
Downgraded
02/26/25
Geron downgraded to Neutral from Buy at B. RileyGeron downgraded to Neutral from Buy at B. Riley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$4$3
Buy
125.56%
Upside
Reiterated
01/29/26
TD Cowen Sticks to Their Buy Rating for Geron (GERN)
Wedbush Analyst forecast on GERN
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$5
Buy
275.94%
Upside
Reiterated
01/13/26
Wedbush Remains a Buy on Geron (GERN)
H.C. Wainwright Analyst forecast on GERN
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
01/12/26
Geron: Tempered 2026 Outlook with Execution Risks and Operational Offsets Supports Hold Rating
Needham Analyst forecast on GERN
Needham
Needham
$4
Buy
200.75%
Upside
Reiterated
01/12/26
Balancing Softer Near-Term Guidance with Capital Discipline and Pipeline Catalysts: Why Geron Merits a Buy Rating and $4 Target
Barclays Analyst forecast on GERN
Barclays
Barclays
$4
Buy
Reiterated
11/03/25
Barclays Sticks to Its Buy Rating for Geron (GERN)
Leerink Partners Analyst forecast on GERN
Leerink Partners
Leerink Partners
$3
Buy
125.56%
Upside
Reiterated
08/12/25
Geron Inc.: Buy Rating Affirmed Amid Promising Leadership and Growth Prospects
Scotiabank Analyst forecast on GERN
Scotiabank
Scotiabank
$1.5
Hold
12.78%
Upside
Reiterated
08/07/25
Scotiabank Reaffirms Their Hold Rating on Geron (GERN)
Goldman Sachs Analyst forecast on GERN
Goldman Sachs
Goldman Sachs
$1
Sell
-24.81%
Downside
Reiterated
07/18/25
We resumed coverage of the Emerging Biotechnology sector last week, including 19 stocks, with Buy ratings on AMLX, AVBP, RNA, CGON, NBIX, RYTM, ROIV, and SNDX, and Sell ratings on ALT and GERN.
Stifel Nicolaus Analyst forecast on GERN
Stifel Nicolaus
Stifel Nicolaus
$4
Buy
200.75%
Upside
Reiterated
03/12/25
Stifel Nicolaus Sticks to Its Buy Rating for Geron (GERN)
Wolfe Research Analyst forecast on GERN
Wolfe Research
Wolfe Research
$3.5$2
Hold
50.38%
Upside
Downgraded
02/26/25
Geron downgraded to Neutral from Buy at B. RileyGeron downgraded to Neutral from Buy at B. Riley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Geron

3 Months
xxx
Success Rate
14/28 ratings generated profit
50%
Average Return
+5.46%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.46% per trade.
1 Year
Gil BlumNeedham
Success Rate
12/28 ratings generated profit
43%
Average Return
+2.62%
reiterated a buy rating 19 days ago
Copying Gil Blum's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +2.62% per trade.
2 Years
xxx
Success Rate
5/12 ratings generated profit
42%
Average Return
-27.82%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -27.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GERN Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
7
7
4
4
5
Buy
0
0
1
1
2
Hold
30
43
62
61
56
Sell
3
0
0
0
0
Strong Sell
0
0
0
0
0
total
40
50
67
66
63
In the current month, GERN has received 7 Buy Ratings, 56 Hold Ratings, and 0 Sell Ratings. GERN average Analyst price target in the past 3 months is 4.00.
Each month's total comprises the sum of three months' worth of ratings.

GERN Financial Forecast

GERN Earnings Forecast

Next quarter’s earnings estimate for GERN is -$0.03 with a range of -$0.05 to -$0.02. The previous quarter’s EPS was -$0.03. GERN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year GERN has Performed in-line its overall industry.
Next quarter’s earnings estimate for GERN is -$0.03 with a range of -$0.05 to -$0.02. The previous quarter’s EPS was -$0.03. GERN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year GERN has Performed in-line its overall industry.

GERN Sales Forecast

Next quarter’s sales forecast for GERN is $50.43M with a range of $46.50M to $51.97M. The previous quarter’s sales results were $47.23M. GERN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year GERN has Performed in-line its overall industry.
Next quarter’s sales forecast for GERN is $50.43M with a range of $46.50M to $51.97M. The previous quarter’s sales results were $47.23M. GERN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year GERN has Performed in-line its overall industry.

GERN Stock Forecast FAQ

What is GERN’s average 12-month price target, according to analysts?
Based on analyst ratings, Geron Corp’s 12-month average price target is 4.00.
    What is GERN’s upside potential, based on the analysts’ average price target?
    Geron Corp has 200.75% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GERN a Buy, Sell or Hold?
          Geron Corp has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Geron Corp’s price target?
            The average price target for Geron Corp is 4.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $5.00 ,the lowest forecast is $3.00. The average price target represents 200.75% Increase from the current price of $1.33.
              What do analysts say about Geron Corp?
              Geron Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of GERN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.